Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

doi:10.1111/j.1365-2125.1990.tb03760.x

Review

. 1990 Aug;30(2):157-71.

doi: 10.1111/j.1365-2125.1990.tb03760.x.

Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

D G Waller¹

Affiliations

PMID: 1976342
PMCID: PMC1368213
DOI: 10.1111/j.1365-2125.1990.tb03760.x

Review

Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

D G Waller. Br J Clin Pharmacol. 1990 Aug.

. 1990 Aug;30(2):157-71.

doi: 10.1111/j.1365-2125.1990.tb03760.x.

Author

D G Waller¹

Affiliation

¹ Clinical Pharmacology Group, Southampton General Hospital.

PMID: 1976342
PMCID: PMC1368213
DOI: 10.1111/j.1365-2125.1990.tb03760.x

No abstract available

PubMed Disclaimer

Cited by

The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.
Fitzgerald JD. Fitzgerald JD. Cardiovasc Drugs Ther. 1991 Jun;5(3):561-76. doi: 10.1007/BF03029726. Cardiovasc Drugs Ther. 1991. PMID: 1678960 Review.
Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol.
Wheeldon NM, McDevitt DG, Lipworth BJ. Wheeldon NM, et al. Br J Clin Pharmacol. 1992 Apr;33(4):411-6. doi: 10.1111/j.1365-2125.1992.tb04060.x. Br J Clin Pharmacol. 1992. PMID: 1349493 Free PMC article. Clinical Trial.
Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
Grove A, Lipworth BJ. Grove A, et al. Thorax. 1996 Jun;51(6):585-9. doi: 10.1136/thx.51.6.585. Thorax. 1996. PMID: 8693438 Free PMC article. Clinical Trial.
Cardiac beta 2-adrenoceptors and the inotropic response to exercise in man.
Nyarko-Adomfeh C. Nyarko-Adomfeh C. Clin Auton Res. 1991 Dec;1(4):317-21. doi: 10.1007/BF01819838. Clin Auton Res. 1991. PMID: 1687999 Clinical Trial.
Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.
Thomas SH, Cooper RC, Ekwuru M, Fletcher S, Gilbody J, Husseyin TS, Ishaque M, Jagathesan R, Reddy G, Smith SE. Thomas SH, et al. Eur J Clin Pharmacol. 1992;42(1):47-53. doi: 10.1007/BF00314919. Eur J Clin Pharmacol. 1992. PMID: 1541316

See all "Cited by" articles

References

1. Eur J Clin Pharmacol. 1988;34(3):255-62 - PubMed
1. J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):749-58 - PubMed
1. Circ Res. 1986 Sep;59(3):297-309 - PubMed
1. Br J Clin Pharmacol. 1987 Nov;24(5):571-80 - PubMed
1. Br Heart J. 1978 Feb;40(2):184-9 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Eur J Clin Pharmacol. 1988;34(3):255-62 - PubMed

[2] Eur J Clin Pharmacol. 1988;34(3):255-62 - PubMed

[3] J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):749-58 - PubMed

[4] J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):749-58 - PubMed

[5] Circ Res. 1986 Sep;59(3):297-309 - PubMed

[6] Circ Res. 1986 Sep;59(3):297-309 - PubMed

[7] Br J Clin Pharmacol. 1987 Nov;24(5):571-80 - PubMed

[8] Br J Clin Pharmacol. 1987 Nov;24(5):571-80 - PubMed

[9] Br Heart J. 1978 Feb;40(2):184-9 - PubMed

[10] Br Heart J. 1978 Feb;40(2):184-9 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Affiliation

Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Author

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources